Efficacy of Exclusive Enteral Nutrition and Weekly Adalimumab Combination in Crohn's Patients With Fibroinflammatory Stenosis

dc.contributor.authorTokmak, Salih
dc.date.accessioned2023-07-26T11:50:18Z
dc.date.available2023-07-26T11:50:18Z
dc.date.issued2021
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.descriptionAdvances in Inflammatory Bowel Diseases (AIBD) Annual Meeting -- DEC 09-11, 2021 -- Orlando, FLen_US
dc.description.abstract[Bastract Not Available]en_US
dc.identifier.endpageS3en_US
dc.identifier.issn0002-9270
dc.identifier.issn1572-0241
dc.identifier.pmid34848599en_US
dc.identifier.startpageS3en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12303
dc.identifier.volume116en_US
dc.identifier.wosWOS:000756689500013en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTokmak, Salih
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofAmerican Journal of Gastroenterologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.titleEfficacy of Exclusive Enteral Nutrition and Weekly Adalimumab Combination in Crohn's Patients With Fibroinflammatory Stenosisen_US
dc.typeConference Objecten_US

Dosyalar